WBB

Analysts at WBB initiated coverage on Cidara Therapeutics Inc (NASDAQ: CDTX) with a Sell rating. The target price for Cidara Therapeutics is set to $13. Cidara Therapeutics' shares declined 0.73 prcent to close at $14.94 yesterday.

WBB Securities upgraded its rating on Cyberonics (NASDAQ: CYBX) to Strong Buy. At the same time, WBB left its price target on the company's stock unchanged at $38. In a research report published today, WBB stressed Cyberonics' strong position in the epilepsy treatment market for its decision. In...